A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence with Inflammatory Bowel DiSease Therapy ASSIST Study

Go Back to All Clinical Trials

A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence with Inflammatory Bowel DiSease Therapy ASSIST Study

Brief description of study

The proposed study is a multicenter, randomized, controlled, clinical trial to be conducted over 12 months. Participants in the intervention arm will verify medication adherence using the Tappt web-based system. Additionally, they will complete a two-item assessment of symptoms monthly. Participants randomized to the control group will receive standard care. All participants are required to complete questionnaires at baseline, 12 weeks, 26 weeks, and 52 weeks.

Clinical Study Identifier: s22-00963

ClinicalTrials.gov Identifier: NCT05316584

Principal Investigator: Jordan E Axelrad.

Other Investigators: Adam Faye, David P Hudesman, Ariela Holmer, Simon J Hong, Shannon Chang.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies